AeroDel

Navi Mumbai, India Founded: 2021 • Age: 5 yrs
Medical devices for respiratory patients are developed by AeroDel.

About AeroDel

AeroDel is a Healthcare company based in Navi Mumbai (India) founded in 2021 by Shradha Sangwai, K K Suraj Rajan, and Zahir Jaffer. It operates as a medical devices for respiratory patients are developed by AeroDel. Its Indian entity Aerodel Technology Innovations Private Limited reported revenue of β‚Ή3.9 Lakh. AeroDel offers products and services including AeroFlex, AerOPEP, JetMist, and SpiroDel. Its focus areas include Life Sciences, Drug Delivery, Inhaled and Pulmonology. Its competitors include MannKind Corp, OptiNose, Impel NeuroPharma, Alexza and Qnovia and 5 more; 9 of its 10 listed competitors have raised funding.

Company details

AeroDel was established in 2021 in Navi Mumbai, India, within the medical devices sector. Devices targeted at patients with respiratory conditions are developed and offered by the company. The AeroDel JetMist is provided as a portable unit that transforms liquid medication into inhalable mist. AeroFlex is also available, consisting of a metered dose inhaler paired with a valve holding chamber to aid in managing respiratory diseases.

  • Headquarters Navi Mumbai, India
  • Founders Shradha Sangwai, K K Suraj Rajan, Zahir Jaffer
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website aerodeltech.com
  • Social LinkedIn
  • Legal Name Aerodel Technology Innovations Pvt Ltd
  • Date of Incorporation 02 Aug, 2023
  • Jurisdiction Thane, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹3.9 Lakh

    FY 2025

  • Net Loss
    -₹71.1 Lakh

    FY 2025 · -1829% margin

  • EBITDA
    -₹70 Lakh

    FY 2025 · -1801% margin

  • Investors

Products & Services of AeroDel

AeroDel offers a comprehensive portfolio of products and services, including AeroFlex, AerOPEP, JetMist, and SpiroDel.

AeroFlex
Medical Device

Next generation VHC to reduce errors and improve drug delivery.

AerOPEP
Respiratory Therapy

Tool for clearing mucus and enhancing lung function in patients.

JetMist
Portable Nebulizer

Battery-powered device for on-the-go respiratory treatments.

SpiroDel
Diagnostic Tool

Hardware-software for screening and monitoring respiratory conditions.

Funding Insights of AeroDel

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of AeroDel with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2024–Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in AeroDel

AeroDel has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include C-CAMP.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Bioscience research, innovation, and entrepreneurship facilitation in life sciences are conducted in India.
2010ccamp.res.inBengaluru, India
Premium access

Investor details for AeroDel

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Aerodel Technology Innovations Private Limited (AeroDel)

Aerodel Technology Innovations Private Limited is the primary company behind AeroDel. The boards of the 2 registered companies of AeroDel currently have 3 directors; the longest-serving is Shradha Mayur Sangwai, appointed in 2020.

DirectorDesignationAppointedTenureEntity
Shradha Mayur Sangwai
DIN 08774679
Designated Partner28 Jun 20206 yrs 3 moAerodel Technologies Llp, Aerodel Technology Innovations Private Limited
Zahir Aziz Jaffer
DIN 07514418
Designated Partner28 Jun 20206 yrs 3 moAerodel Technologies Llp, Aerodel Technology Innovations Private Limited
Kanyan Kandi Suraj Rajan
DIN 07568206
Director02 Aug 20233 yrs 2 moAerodel Technology Innovations Private Limited

People of AeroDel

3 people are tracked at AeroDel (3 in leadership).

NameRoleGroup
Co-FounderLeadership
K K Suraj Rajan
Co-FounderLeadership
Co-FounderLeadership
Premium access

Complete people profiles for AeroDel

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of AeroDel

Figures of Aerodel Technology Innovations Private Limited, the primary company behind AeroDel, for FY 2025. Revenue was ₹3.9 Lakh. Net loss was -₹71.1 Lakh (-1829% margin). EBITDA was -₹70 Lakh (-1801% margin).

  • ₹3.9 LakhRevenue · FY 2025
  • -₹71.1 LakhNet loss · -1829% margin
  • -₹70 LakhEBITDA · -1801% margin
  • ₹1.2 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Aerodel Technology Innovations Private Limited are on its company page.

Premium access

Detailed financial statements for AeroDel

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of AeroDel

2 dated milestones of AeroDel across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded AeroDel is founded.
  2. Funding First funding round.

Competitors of AeroDel

AeroDel has 10 listed competitors in our database, 9 of them funded. They include MannKind Corp, OptiNose, Impel NeuroPharma, Alexza and Qnovia, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
mannkindcorp.com1991Los Angeles, United States$50M322
Developer of small-molecule drugs
optinose.com2000Morrisville, United States$120.5M132
Developer of smart devices for nasal drug delivery
impelnp.com2008Seattle, United States$126.83M158
Intranasal delivery technology for CNS diseases is developed.
alexza.com2000Mountain View, United States$97M72
Developer of products for the treatment of acute and intermittent conditions
qnovia.com2018Richmond, United States$38.12M–
Inhaled drug delivery devices are developed for pharmaceuticals.
iconovo.se2013Lund, Sweden$3.56M–
Inhalation devices for medical applications are developed by Iconovo.
aerami.com2010Durham, United States$151.1M–
Therapeutics for cardiopulmonary diseases are developed using inhaled therapies.
nobhilltherapeutics.com2016Albuquerque, United States$3.67M–
Dry powder nebulizer is developed for targeted lung drug delivery.
beyondair.net2011Garden, United States––
Developer of device for treating respiratory conditions
nebuflow.com2019Glasgow, United Kingdom$7.97M–
Aerosol delivery platform technology is developed for medical applications.
Premium access

Detailed competitors of AeroDel

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

10 companies that operate in the same segment as AeroDel (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about AeroDel

AeroDel was founded in 2021 and raised its 1st funding round 3 years after it was founded.

AeroDel is headquartered in Navi Mumbai, India. It is registered at Navi Mumbai, Maharashtra, India.

The primary company behind AeroDel, Aerodel Technology Innovations Private Limited, reported revenue of β‚Ή3.9 Lakh for FY 2025.

AeroDel was established in 2021 in Navi Mumbai, India, within the medical devices sector. Devices targeted at patients with respiratory conditions are developed and offered by the company. The AeroDel JetMist is provided as a portable unit that transforms liquid medication into inhalable mist. AeroFlex is also available, consisting of a metered dose inhaler paired with a valve holding chamber to aid in managing respiratory diseases.

AeroDel's top competitors include MannKind Corp, OptiNose and Impel NeuroPharma.

AeroDel offers AeroFlex, AerOPEP, JetMist, and SpiroDel.

AeroDel has 1 investor. Key investors include C-CAMP.

AeroDel is associated with 2 legal entities: Aerodel Technology Innovations Private Limited, Aerodel Technologies Llp.

The legal entities of AeroDel currently have 3 directors, including Shradha Mayur Sangwai, Zahir Aziz Jaffer, Kanyan Kandi Suraj Rajan.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available